References
- Abdelali, A., Al-Bader, M., Kilarkaje, N. (2016). Effects of trans-resveratrol on hyperglycemia-induced abnormal spermatogenesis, DNA damage and alterations in poly (ADP-ribose) polymerase signaling in rat testis. Toxicol. Appl. Pharmacol., 311, 61–73.
- Buraka, E., Chen, C. Y., Gavare, M., Grube, M., Makarenkova, G., Nikolajeva V., Bisenieks, I., Brūvere, I., Bisenieks, E., Duburs, G., Sjakste, N. (2014). DNA-binding studies of AV-153, an antimutagenic and DNA repair-stimulating derivative of 1,4-dihydropiridine. Chem. Biol. Interact., 220, 200–207.
- Dišlere, K., Rostoka, E., Bisenieks, E., Duburs, G., Paramonova, N., Sjakste, N. (2021). 1,4-dihydropyridine derivatives increase mRNA expression of Psma3, Psmb5, and Psmc6 in rats. Arh. Hig. Rada Toksikol., 72 (3), 148–156.
- Goncharova, R., Zabrejko, S., Dalivelya, O., Kuzhir, T. (2001). Anticlastogenicity of two derivatives of 1,4-dihydroisonicotinic acid in mouse micronucleus test. Mutat. Res., 496 (1–2), 129–35.
- Jeddi, S., Yousefzadeh, N., Kashfi, K., Ghasemi, A. (2022). Role of nitric oxide in type 1 diabetes-induced osteoporosis. Biochem. Pharmacol., 197, 114888.
- Kopf, S., Kumar, V., Kender, Z., Han, Z., Fleming, T., Herzig, S., Nawroth, P. P. (2021). Diabetic pneumopathy — A new diabetes-associated complication: Mechanisms, consequences and treatment considerations. Front Endocrinol. (Lausanne), 12, 765201.
- Leonova, E., Dišlere, K., Rostoka, E., Baumane, L., Bisenieks, E., Duburs, G., Sjakste, N. (2023). Study of impact of a 1,4-DHP derivative glutapyrone on DNA using in vitro tests. Proc. Latv. Acad. Sci., 77 (1), 49–52.
- Leonova, E., Ošiņa, K., Duburs, G., Bisenieks, E., Germini, D., Vassetzky, Y., Sjakste, N. (2019). Metal ions modify DNA-protecting and mutagenscavenging capacities of the AV-153 1,4-dihydropyridine. Mutat. Res., 845, 403077.
- Leonova, E., Rostoka, E., Baumane, L., Borisovs, V., Smelovs, E., Bisenieks, I., Brūvere, I., Bisenieks, E., Duburs, G., Sjakste, N. (2018a). DNA-binding studies of a series of novel water-soluble derivatives of 1,4-dihydropyridine. Biopolymers Cell, 34 (2), 129–142.
- Leonova, E., Rostoka, E., Sauvaigo, S., Baumane, L., Selga, T., Sjakste, N. (2018b) Study of interaction of antimutagenic 1,4-dihydropyridine AV-153-Na with DNA-damaging molecules and its impact on DNA repair activity. PeerJ., 6, e4609.
- Leonova, E., Sokolovska, J., Boucher, J. L., Isajevs, S., Rostoka, E., Baumane, L., Sjakste, T., Sjakste, N. (2016) New 1,4-dihydropyridines down-regulate nitric oxide in animals with streptozotocin-induced diabetes mellitus and protect DNA against peroxynitrite action. Basic Clin. Pharmacol. Toxicol., 119 (1), 19–31.
- Milković, L., Vukovic, T., Zarkovic, N., Tatzber, F., Bisenieks, E., Kalme, Z., Bruvere, I., Ogle, Z., Poikans, J., Velena, A., Duburs, G. (2018). Antioxidative 1,4-dihydropyridine derivatives modulate oxidative stress and growth of human osteoblast-like cells in vitro. Antioxidants (Basel), 7 (9), 123.
- Novoselova, E. G., Glushkova, O. V., Khrenov, M. O., Lunin, S. M., Novoselova, T. V., Parfenuyk, S. B. (2021). Role of innate immunity and oxidative stress in the development of type 1 diabetes mellitus. Peroxiredoxin 6 as a new anti-diabetic agent. Biochemistry (Mosc), 86 (12), 1579–1589.
- Ošiņa, K. (2019). The effect of 1,4-dihydropyridine derivatives on expression of DNA repair and proteolysis enzymes in diabetes mellitus and the level of DNA breaks in vitro. Doctoral dissertation, University of Latvia, Rīga, Latvia.
- Ošiņa, K., Rostoka, E., Sokolovska, J., Paramonova, N., Bisenieks, E., Duburs, G., Sjakste, N., Sjakste, T. (2016). 1,4-Dihydropyridine derivatives without Ca2+-antagonist activity up-regulate Psma6 mRNA expression in kidneys of intact and diabetic rats. Cell Biochem. Funct., 34 (1), 3–6.
- Ošiņa, K., Leonova, E., Isajevs, S., Baumane, L., Rostoka, E., Sjakste, T., Bisenieks, E., Duburs, G., Vīgante, B., Sjakste, N. (2017). Modifications of expression of genes and proteins involved in DNA repair and nitric oxide metabolism by carbatonides [disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives] in intact and diabetic rats. Arh. Hig. Rada Toksikol., 68 (3), 212–227.
- Ošiņa, K., Rostoka, E., Isajevs, S., Sokolovska, J., Sjakste, T., Sjakste, N. (2016). Effects of an antimutagenic 1,4-dihydropyridine AV-153 on expression of nitric oxide synthases and DNA repair-related enzymes and genes in kidneys of rats with a streptozotocin model of diabetes mellitus. Basic Clin. Pharmacol. Toxicol., 119 (5), 458–463.
- Ponomareva, T. V., Romanovich, I. K., Bisenieks, E. A., Vartanian, L. P., Yershov, E. B., Merkushev, G. N. (2018). Dihydropyridines in Treatment and Prophylaxis of Lesions Induced by Radioactivity. Book 2. Anticarcinogenic, Stress Protecting and Radiomitigating Action of 1,4-Dihydropyridines and Dihydroindenolpyridines. Experimental studies [Пономарева T. В., Романович И. К., Бисениекс Э. А., Вартанян Л. П., Ершов Э. Б., Меркушев Г. Н. Дигидропиридиныг в лечении и профилактике лучевыыс поражений. Книга 2. Антиканцерогенныге, стрессопртекторныге свойсва и радиосенсибилизирующее действие дигидропиридинов и 1,4-дигидроинденолпиридинов. Эксперимен-талъныге исследования]. Saint-Petersburg, 471 pp. (in Russian).
- Ramani, S., Pathak, A., Dalal, V., Paul, A., Biswas, S. (2020). Oxidative stress in autoimmune diseases: An under dealt malice. Curr. Protein Pept. Sci., 21 (6), 611–621.
- Rostoka, E., Salna, I., Dekante, A., Pahirko, L., Borisovs, V., Celma, L., Valeinis, J., Sjakste, N., Sokolovska, J. (2021). DNA damage in leukocytes and serum nitrite concentration are negatively associated in type 1 diabetes. Mutagenesis, 36 (3), 213–222.
- Sarras, M. P. Jr., Mason, S., McAllister, G., Intine, R. V. (2014). Inhibition of poly-ADP ribose polymerase enzyme activity prevents hyperglycemia-induced impairment of angiogenesis during wound healing. Wound Repair Regen., 22 (5), 666–670.
- Sokolovska, J., Dekante, A., Baumane, L., Pahirko, L., Valeinis, J., Dislere, K., Rovite, V., Pirags, V., Sjakste, N. (2020). Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy. Biomed. Rep., 12 (5), 251–258.
- Velena, A., Zarkovic, N., Troselj, K. G., Bisenieks, E., Krauze, A., Poikans, J., Duburs, G. (2016). 1,4-Dihydropyridine derivatives: Dihydronicotin-amide analogues-model compounds targeting oxidative stress. Oxid. Med. Cell Longev., 1892412.
- Wang, M., Li, Y., Li, S., Lv, J. (2022). Endothelial dysfunction and diabetic cardiomyopathy. Front Endocrinol. (Lausanne), 13, 851941.